Acrivon Therapeutics, Inc.
ACRV
$2.05
-$0.05-2.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 89.96M | 97.74M | 118.58M | 129.25M | 137.42M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.53M | 1.48M | 1.86M | 1.11M | 989.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 91.49M | 99.22M | 120.45M | 130.36M | 138.41M |
|
|
|||||
| Total Current Assets | 91.49M | 99.22M | 120.45M | 130.36M | 138.41M |
| Net Property, Plant & Equipment | 6.23M | 6.91M | 7.42M | 7.98M | 8.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.37M | 1.70M | 1.86M | 1.85M | 1.85M |
| Total Assets | 99.09M | 107.83M | 129.72M | 145.30M | 158.58M |
|
|
|||||
| Total Accounts Payable | 861.00K | 1.16M | 2.28M | 996.00K | 1.16M |
| Total Accrued Expenses | 9.45M | 8.74M | 12.07M | 12.71M | 10.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.14M | 1.15M | 1.17M | 1.18M | 1.15M |
| Total Finance Division Other Current Liabilities | -- | -- | 143.00K | -- | 565.00K |
| Total Other Current Liabilities | -- | -- | 143.00K | -- | 565.00K |
| Total Current Liabilities | 11.45M | 11.05M | 15.66M | 14.89M | 13.43M |
|
|
|||||
| Total Current Liabilities | 11.45M | 11.05M | 15.66M | 14.89M | 13.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 980.00K | 1.26M | 1.54M | 1.81M | 2.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.43M | 12.32M | 17.20M | 16.70M | 15.55M |
|
|
|||||
| Common Stock & APIC | 398.59M | 389.43M | 387.29M | 384.39M | 380.59M |
| Retained Earnings | -311.89M | -293.92M | -274.88M | -255.90M | -237.66M |
| Treasury Stock & Other | -33.00K | 4.00K | 111.00K | 112.00K | 106.00K |
| Total Common Equity | 86.67M | 95.52M | 112.52M | 128.60M | 143.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 86.67M | 95.52M | 112.52M | 128.60M | 143.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 86.67M | 95.52M | 112.52M | 128.60M | 143.04M |
|
|
|||||